Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-12 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
mRNA | ZNF708 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-12 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-12 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-12 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-12 |
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |